戴 世光

Medicine & Life Sciences

1. Squamous Cell Carcinoma 100%
2. Squamous Cell Carcinoma of Head and Neck 90%
3. Head and Neck Neoplasms 89%
4. Neoplasms 55%
5. Cisplatin 48%
6. Cetuximab 40%
7. Chemoradiotherapy 39%
8. Neck Dissection 37%
9. Neck 37%
10. Survival 36%
11. Hypopharyngeal Neoplasms 35%
12. Neoplasm Metastasis 31%
13. Tongue 29%
14. Epithelial-Mesenchymal Transition 25%
15. Recurrence 23%
16. Second Primary Neoplasms 21%
17. Induction Chemotherapy 20%
18. Carcinoma 19%
19. Therapeutics 19%
20. Pyriform Sinus 19%
21. Radiotherapy 17%
22. Laryngectomy 16%
23. Macrophages 16%
24. Lymph Nodes 15%
25. Larynx 14%
26. Snails 14%
27. Fluorouracil 14%
28. Hypopharynx 13%
29. Mouth 13%
30. Vocal Cords 12%
31. Drug Therapy 12%
32. Fistula 12%
33. Mouth Neoplasms 12%
34. Mandibular Osteotomy 11%
35. Organ Preservation 11%
36. Thyroid Neoplasms 11%
37. Veterans Hospitals 10%
38. CREB-Binding Protein 10%
39. Methotrexate 10%
40. Matrix Metalloproteinase 17 10%
41. Cell Biology 10%
42. lonafarnib 9%
43. Head 9%
44. Tonsillectomy 9%
45. Laryngeal Tuberculosis 9%
46. Stents 9%
47. Protein-Arginine N-Methyltransferases 9%
48. Disease-Free Survival 9%
49. Narrow Band Imaging 9%